Prediction of significant conduction disease through noninvasive assessment of cardiac calcification.
Publication/Presentation Date
10-1-2012
Abstract
AIMS: Cardiac calcification is associated with coronary artery disease, arrhythmias, conduction disease, and adverse cardiac events. Recently, we have described an echocardiographic-based global cardiac calcification scoring system. The objective of this study was to evaluate the severity of cardiac calcification in patients with permanent pacemakers as based on this scoring system.
METHODS AND RESULTS: Patients with a pacemaker implanted within the 2-year study period with a previous echocardiogram were identified and underwent blinded global cardiac calcium scoring. These patients were compared to matched control patients without a pacemaker who also underwent calcium scoring. The study group consisted of 49 patients with pacemaker implantation who were compared to 100 matched control patients. The mean calcium score in the pacemaker group was 3.3 ± 2.9 versus 1.8 ± 2.0 (P = 0.006) in the control group. Univariate and multivariate analysis revealed glomerular filtration rate and calcium scoring to be significant predictors of the presence of a pacemaker.
CONCLUSION: Echocardiographic-based calcium scoring correlates with the presence of severe conduction disease requiring a pacemaker.
Volume
29
Issue
9
First Page
1017
Last Page
1021
ISSN
1540-8175
Published In/Presented At
Mainigi, S. K., Chebrolu, L. H., Romero-Corral, A., Mehta, V., Machado, R. R., Konecny, T., & Pressman, G. S. (2012). Prediction of significant conduction disease through noninvasive assessment of cardiac calcification. Echocardiography (Mount Kisco, N.Y.), 29(9), 1017–1021. https://doi.org/10.1111/j.1540-8175.2012.01752.x
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
22672350
Department(s)
Administration and Leadership
Document Type
Article